Telix and Radius Sign Italian Distribution Agreement for Prostate Cancer Imaging

NEXT STORY
MacroGenics Announces Presentations at ESMO 2021 Virtual Annual Congress
PREV STORY
Samsung Bioepis Announces Five-year Follow-up Results for ONTRUZANT® (trastuzumab) in Early or Locally Advanced HER2 Positive Breast Cancer at the European Society for Medical Oncology (ESMO) Virtual Congress 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

XBiotech Announces Grand Opening Date for New Commercial Manufacturing Facility

AUSTIN, Texas, Aug. 22, 2016 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT), developer of next-generation ...

author_avatar
NASDAQ Market News

Study Demonstrates Macrolide-Resistance in S. pneumoniae in the United States Exceeds 25 Percent Threshold Set in Current Community-Acquired Bacterial Pneumonia (CABP) Treatment Guidelines

author_avatar
NASDAQ Market News

XBiotech to Present at Cantor Fitzgerald’s Global Healthcare Conference

AUSTIN, Texas, Sept. 21, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that ...

author_avatar
NASDAQ Market News